Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Remmers

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
BJU International|November 21, 2022
Shifting risk-stratified early prostate cancer detection to a primary healthcare settingRenée Hogenhout, Daniël F Osses, Arnout R Alberts, et al.
World Journal of Urology|March 22, 2026
Experience of 5 years adjustable continence therapy (ProACT): the surgical learning curve and patient outcomesLisa M de Zeeuw, Coen H H Christiaans, Sebastiaan Remmers, et al.
Journal of Personalized Medicine|January 27, 2026
Treatment-Free Survival and the Pattern of Follow-Up Treatments After Curative Prostate Cancer Treatment, a Real-World Analysis of Big Data from Electronic Health Records from a Tertiary CenterFréderique B Denijs, Sebastiaan Remmers, Leonard P Bokhorst, et al.
European Urology Open Science|August 1, 2022
Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer RotterdamRenée Hogenhout, Ivo I de Vos, Sebastiaan Remmers, et al.
European Urology Open Science|January 3, 2022
Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative BiopsySebastiaan Remmers, Daan Nieboer, L Lucia Rijstenberg, et al.
European Urology Focus|December 7, 2020
Europa Uomo Patient Reported Outcome Study (EUPROMS): Descriptive Statistics of a Prostate Cancer Survey from Patients for PatientsLionne D F Venderbos, André Deschamps, John Dowling, et al.
European Urology Focus|June 2, 2023
The Europa Uomo Patient Reported Outcome Study 2.0-Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-makingLionne D F Venderbos, Sebastiaan Remmers, André Deschamps, et al.
European Urology Oncology|November 27, 2024
Reducing Overtreatment of Prostate Cancer Patients: Revisiting the European Association of Urology Pretreatment Risk Group Classification Using Long-term Follow-up Data from the European Randomized Study of Screening for Prostate Cancer RotterdamIvo I de Vos, Charlotte Rosenstand, Renée Hogenhout, et al.
Translational Andrology and Urology|July 23, 2021
Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patientsR Trafford Crump, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2024
Does prostate cancer without cribriform pattern have metastatic potential?Lisa J Kroon, Sebastiaan Remmers, Eva Hollemans, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
BJU International|November 21, 2022
Shifting risk-stratified early prostate cancer detection to a primary healthcare settingRenée Hogenhout, Daniël F Osses, Arnout R Alberts, et al.
World Journal of Urology|March 22, 2026
Experience of 5 years adjustable continence therapy (ProACT): the surgical learning curve and patient outcomesLisa M de Zeeuw, Coen H H Christiaans, Sebastiaan Remmers, et al.
Journal of Personalized Medicine|January 27, 2026
Treatment-Free Survival and the Pattern of Follow-Up Treatments After Curative Prostate Cancer Treatment, a Real-World Analysis of Big Data from Electronic Health Records from a Tertiary CenterFréderique B Denijs, Sebastiaan Remmers, Leonard P Bokhorst, et al.
European Urology Open Science|August 1, 2022
Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer RotterdamRenée Hogenhout, Ivo I de Vos, Sebastiaan Remmers, et al.
European Urology Open Science|January 3, 2022
Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative BiopsySebastiaan Remmers, Daan Nieboer, L Lucia Rijstenberg, et al.
European Urology Focus|December 7, 2020
Europa Uomo Patient Reported Outcome Study (EUPROMS): Descriptive Statistics of a Prostate Cancer Survey from Patients for PatientsLionne D F Venderbos, André Deschamps, John Dowling, et al.
European Urology Focus|June 2, 2023
The Europa Uomo Patient Reported Outcome Study 2.0-Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-makingLionne D F Venderbos, Sebastiaan Remmers, André Deschamps, et al.
European Urology Oncology|November 27, 2024
Reducing Overtreatment of Prostate Cancer Patients: Revisiting the European Association of Urology Pretreatment Risk Group Classification Using Long-term Follow-up Data from the European Randomized Study of Screening for Prostate Cancer RotterdamIvo I de Vos, Charlotte Rosenstand, Renée Hogenhout, et al.
Translational Andrology and Urology|July 23, 2021
Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patientsR Trafford Crump, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2024
Does prostate cancer without cribriform pattern have metastatic potential?Lisa J Kroon, Sebastiaan Remmers, Eva Hollemans, et al.
Pageof 10